BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rofo F, Ugur Yilmaz C, Metzendorf N, Gustavsson T, Beretta C, Erlandsson A, Sehlin D, Syvänen S, Nilsson P, Hultqvist G. Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain. Theranostics 2021;11:789-804. [PMID: 33391505 DOI: 10.7150/thno.50263] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang B, Zhu T, Liu L, Yuan L. In vitro electrochemical detection of the degradation of amyloid-β oligomers. Journal of Colloid and Interface Science 2023;629:156-165. [DOI: 10.1016/j.jcis.2022.09.009] [Reference Citation Analysis]
2 Rosa ADL, Metzendorf NG, Morrison JI, Faresjö R, Rofo F, Petrovic A, O’callaghan P, Syvänen S, Hultqvist G. Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3.. [DOI: 10.21203/rs.3.rs-2166577/v1] [Reference Citation Analysis]
3 Williams D, Yan BQ, Wang H, Negm L, Sackmann C, Verkuyl C, Rezai-stevens V, Eid S, Sato C, Watts JC, Wille H, Schmitt-ulms G. Somatostatin slows Aβ plaque deposition in aged APPNL-F/NL-F mice by blocking Aβ aggregation in a neprilysin-independent manner.. [DOI: 10.1101/2022.09.26.509540] [Reference Citation Analysis]
4 Liu Y, Yang G, Cui W, Zhang Y, Liang X. Regulatory mechanisms of tetramethylpyrazine on central nervous system diseases: A review. Front Pharmacol 2022;13:948600. [DOI: 10.3389/fphar.2022.948600] [Reference Citation Analysis]
5 Rofo F, Meier SR, Metzendorf NG, Morrison JI, Petrovic A, Syvänen S, Sehlin D, Hultqvist G. A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice. Neurotherapeutics 2022. [PMID: 35939261 DOI: 10.1007/s13311-022-01283-y] [Reference Citation Analysis]
6 Syvänen S, Meier SR, Roshanbin S, Xiong M, Faresjö R, Gustavsson T, Bonvicini G, Schlein E, Aguilar X, Julku U, Eriksson J, Sehlin D. PET Imaging in Preclinical Anti-Aβ Drug Development. Pharm Res 2022. [PMID: 35501533 DOI: 10.1007/s11095-022-03277-z] [Reference Citation Analysis]
7 Schreiner TG, Popescu BO. Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact. JCM 2021;10:5986. [DOI: 10.3390/jcm10245986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Jeong H, Kim OJ, Oh SH, Lee S, Reum Lee HA, Lee KO, Lee BY, Kim NK. Extracellular Vesicles Released from Neprilysin Gene-Modified Human Umbilical Cord-Derived Mesenchymal Stem Cell Enhance Therapeutic Effects in an Alzheimer's Disease Animal Model. Stem Cells Int 2021;2021:5548630. [PMID: 34899919 DOI: 10.1155/2021/5548630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Rofo F, Buijs J, Falk R, Honek K, Lannfelt L, Lilja AM, Metzendorf NG, Gustavsson T, Sehlin D, Söderberg L, Hultqvist G. Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta. Transl Neurodegener 2021;10:38. [PMID: 34579778 DOI: 10.1186/s40035-021-00258-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Qian C, Yang C, Lu M, Bao J, Shen H, Deng B, Li S, Li W, Zhang M, Cao C. Activating AhR alleviates cognitive deficits of Alzheimer's disease model mice by upregulating endogenous Aβ catabolic enzyme Neprilysin. Theranostics 2021;11:8797-812. [PMID: 34522212 DOI: 10.7150/thno.61601] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Gonzalez-Rodriguez M, Astillero-Lopez V, Villanueva-Anguita P, Paya-Rodriguez ME, Flores-Cuadrado A, Villar-Conde S, Ubeda-Banon I, Martinez-Marcos A, Saiz-Sanchez D. Somatostatin and Astroglial Involvement in the Human Limbic System in Alzheimer's Disease. Int J Mol Sci 2021;22:8434. [PMID: 34445147 DOI: 10.3390/ijms22168434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Matiadis D, Ng ST, Chen EH, Nigianni G, Vidali VP, Canko A, Chen RP, Sagnou M. Synthesis and Biological Evaluation of Hydroxylated Monocarbonyl Curcumin Derivatives as Potential Inducers of Neprilysin Activity. Biomedicines 2021;9:955. [PMID: 34440159 DOI: 10.3390/biomedicines9080955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Rofo F, Sandbaumhüter FA, Chourlia A, Metzendorf NG, Morrison JI, Syvänen S, Andrén PE, Jansson ET, Hultqvist G. Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide. ACS Chem Neurosci 2021;12:2529-41. [PMID: 34170117 DOI: 10.1021/acschemneuro.1c00303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kumar AH. Modelling the efficacy of Neprilysin from various species in degrading different Amyloid-β peptides: Potential application in therapeutics of Alzheimer’s disease.. [DOI: 10.1101/2021.03.25.436981] [Reference Citation Analysis]